Fig. 3From: Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysisThe progression-free survival (PFS) (A) and OS (B) curves for 91 cases with GTR (left) and each curve of the cases divided by type of combination therapy consisting of TMZ + IMT, TMZ, BEV with or without TMZ, and others (right). The log-rank test was used for analysisBack to article page